Brief: Silo Pharma Files Patent For Groundbreaking Ketamine Implant Therapeutic To Target Fibromyalgia And Chronic Pain
18/03/2024 11:26
March 18 (Reuters) - Silo Pharma Inc SILO.O :
* SILO PHARMA FILES PATENT FOR GROUNDBREAKING KETAMINE
IMPLANT
THERAPEUTIC TO TARGET FIBROMYALGIA AND CHRONIC PAIN
Source text for Eikon: ID:nGNX69Xgzl
Further company coverage: SILO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement